Home › Funds › Renaissance Investment Group LLC › ABT

Renaissance Investment Group LLC position in ABT

ABBOTT LABORATORIES · Health Care

Renaissance Investment Group LLC reported holding 9,653 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$954K, representing 0.20% of its reported portfolio and ranking #45 among its reported holdings. Renaissance Investment Group LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)9.65K sh
Reported value held$954.01K
Portfolio Weight0.20%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Renaissance Investment Group LLC's ABT position evolved

Renaissance Investment Group LLC first disclosed a stake in ABT in Q3 2023 at 14,104 shares (US$1.4M). The position peaked in Q4 2023 at 14,204 shares, worth US$1.6M. Across 13 filings, Renaissance Investment Group LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 9,653 shares valued at US$954K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.10K $1.37M New
Q4 2023 14.20K $1.56M Add
Q1 2024 13.70K $1.56M Reduce
Q2 2024 12.77K $1.30M Reduce
Q3 2024 12.75K $1.45M Hold
Q4 2024 11.32K $1.28M Reduce
Q1 2025 10.14K $1.35M Reduce
Q2 2025 10.14K $1.38M Hold
Q3 2025 9.64K $1.29M Reduce
Q4 2025 9.59K $1.20M Reduce
Q1 2026 9.40K $965.20K Reduce
Q2 2026 9.66K $876.82K Add
Q3 2026 9.65K $954.01K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Renaissance Investment Group LLC held ABT?

Renaissance Investment Group LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Renaissance Investment Group LLC's current position in ABT?

As of Q3 2026, Renaissance Investment Group LLC holds 9.65K shares of ABT (ABBOTT LABORATORIES), valued at $954.01K, representing 0.20% of its reported portfolio and ranking #45.

Has Renaissance Investment Group LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Renaissance Investment Group LLC held unchanged its position in ABT. The position peaked in Q4 2023 at 14.20K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.